Roger Montgomery's views on today's announcement can be found in his website rogermontgomery.com.
The fund moved to re-purchase allocations of their portfolio they had earlier divested at its height, citing over reaction, confusing report whilst stressing that positive results on SIR Spheres efficacy on its treatment of liver cancer if it has not spread to other parts of the body. Go read for yourself, SRX shareholders can feel more positive ahead and those who bought today could proudly pat themselves for the courage to do so alongside astute Roger.
Roger Montgomery on Sirtex
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $57.30M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $43.95K | 337.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 204567 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 488141 | 11 |
View Market Depth
| Last trade - 14.03pm 14/05/2024 (20 minute delay) ? |
| SRX (ASX) Chart |